$15.82
-0.29-1.8%
最終更新: Oct 2, 7:07 AM
$15.94
-0.17-1.06%
Benzinga
Benzinga
Benzinga
金曜日, 10 02
Benzinga
© 2026 Benzinga | All Rights Reserved
Dyne Therapeutics (DYN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.75 | $-0.77 | $-0.75 | $-0.83 |
| Actual | $-1.08 | $-0.73 | $-0.76 | $-0.76 |
| Surprise | -44.0% | +5.19% | -1.33% | +8.43% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.89 | $-0.88 | $-0.89 | $-0.85 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-1.08 | $-0.75 | -44.0 % |
| Q1 | May 11, 2026 | $-0.73 | $-0.77 | 5.19 % |
| Q4 | Mar 2, 2026 | $-0.76 | $-0.75 | -1.33 % |
| Q3 | Nov 5, 2025 | $-0.76 | $-0.83 | 8.43 % |